Purchase this article with an account.
Dawn A Sim, Colin J Chu, Michael B Powner, Senthil Selvam, Adnan Tufail, Catherine A Egan, James W B Bainbridge, Richard W J Lee, Andrew D Dick, Marcus Fruttiger; Depot Indocyanine Green Dye for in vivo visualization of infiltrating leukocytes. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4117. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To assess a novel method to label and image myeloid cells infiltrating the mouse retina and choroid in vivo, using a single depot injection of Indocyanine green dye (ICG).
We assess the use of depot ICG for the purpose of in vivo cell labelling on three different ocular models of inflammation and angiogenesis - endotoxin-induced uveitis (EIU), experimental autoimmune uveoretinitis (EAU) and laser-induced choroidal neovascularisation (CNV) model. A near-infrared scanning ophthalmoscope was used for in vivo imaging of the eye and flow cytometry was used on blood and spleen to assess the number and phenotype of labelled cells. ICG was administered 72 hours prior to the induction of inflammation to ensure clearance from systemic circulation.
We found that in vivo intravenous administration failed to label any leukocytes, whereas depot injection, either intraperitoneal or subcutaneous, was successful in labelling CD11b+ myeloid cells. Progression of inflammation could be traced over a period of 14 days following a single depot injection of ICG. Additionally, flow cytometric analysis revealed that the predominant population of cells stained by ICG are circulating and splenic reservoir CD11b+ myeloid cells.
The translation of this approach into clinical practice would enable visualisation of immune cells in situ. This will not only provide a greater understanding of pathogenesis, monitoring and assessment of therapy in many human ocular diseases but also opens the ability to image immunity live for neurodegenerative disorders, cardiovascular disease and systemic immune mediated disorders.
This PDF is available to Subscribers Only